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AbStrAct
Cancer is the second cause of death in Portugal right after cardio vascular diseases. In Portugal the incidence of oral 
and pharynx cancer (OPC) is higher than uterus and larynx cancers, and in US its frequency is higher than melanoma 
or uterus cancer, diseases that concern more population than oral cancer.
Aims
The aim of this paper is to identify preferable anatomic location for oral cancer, mean age of patients, the use of tobacco 
and alcohol, histological characteristics, staging, type of therapeutics, presence of metastases and 1 and 5 year follow 
up.
Matherials and Methods
Data was collected from clinical charts of 365 cases from the Centro de Lisboa do Instituto Português de Oncologia 
with histological confirmation of malign tumor of the mouth. These cases are the total of oral malign tumors in the 
years of 1997, 1998 and 1999 in that institution.
Results
We observe that despite modern diagnostic and treatment techniques 37,9% of all patients died after first year with 
evidence of tumor. From all patients just 23,7% were free of disease after 5 years of treatment. Tongue was the principal 
region affected and the average age was 62, 25 years. It was concluded that 57, 8% of patient were smokers and 43,8% 
were alcohol drinkers. A high number of patients were submitted to radiotherapy either alone or with other treatment 
options.
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IntroDuctIon
Cancer is the second cause of death in Portugal, right after 
cardiovascular diseases (CVD), and head and neck cancer 
accounts for 10% of all malign cancers. In Portugal the in-
cidence of oral and pharyngeal cancer (OPC) is higher than 
uterus and larynx cancers, and in United States estimated 
deaths for this cancer are higher than melanoma or uterus 
cancer, which are more concerning diseases than OPC for 
population in general, even if OPC has severe consequences, 
not only functional but also psychologically (1-2).
The death rate for OPC in males starts to rise in mid eighties. 
Between 1988 and 1998 and an increase of 24% was noticed 
compared to earlier years. This increase affected mainly 
middle age and young males following a pattern where the 
incidence age was decreasing (3-5).
Trends in oral cancer incidence rates that include all oral 
sites may be misleading. For example, risk factors for lip 
cancer are different from intraoral sites. Also because there 
are differences in oral cancer incidence rates by age, ana-
tomic site, treatment and geographic location (6-10). Thus, 
descriptive oral cancer data for each geographic area are 
important to understand the extent of the problem (11-13). 
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The purpose of this study is to analyze a large case series of 
oral cancer emphasing risk factors and outcome. 
MAterIAlS AnD MethoDS
A total of 365 files with a histopathological diagnosis of 
primary malignant neoplasm of the mouth were reviewed. 
Data collected from patient records included patient gender, 
anatomic location (buccal mucosa, tongue, floor of  the 
mouth, gingival and palate)(ICD-O, International Classi-
fication of Disease- Oncology)(14), pre-treatment staging, 
treatment options, metastases evidence, recurrence, 1 and 
5 year follow-up, tobacco and alcoholic habits, association 
with other tumours of the upper aero digestive tract and 
outcome. Lip cancer was not considered because it has 
different risk factors. Descriptive analyses of the variables 
was made using software SPSS for windows.
Information on alcohol consumption included the type of 
alcoholic beverage. Taking into account the different alcohol 
concentrations for each beverage, we considered someone 
with alcoholic habits who drunk more than 12 g of ethanol a 
day. At the some time a smoker was define as someone who 
smoke more than a cigarette a day for more than a year.
reSultS
Epidemiological research concerning oral cancer is complex 
due to the existence of multiple anatomic regions and sub-
regions. The anatomic location was identified by anatomic 
sub-regions whenever possible. All results show frequency 
of each variable.
Eighty percent of the 365 oral cancer cases was diagnosed in 
males. The overall male-to-female ratio was 4.0.  The average 
age of diagnosis of malignant neoplasm was 62 years old 
with a standard deviation of nearly 12 years.
Anatomic location was registered and coded according to 
the recommendations of the ICD-O (International Classifi-
cation of Disease – Oncology). The anatomic location distri-
bution indicates that the tongue and its sub-regions (C01.9 
to C02.9) were involved in about 43% of the cases. Other 
sites with significant results were: floor of the mouth and 
its sub-regions (C04.0 to C04.9) with approximately 18,9%; 
palate (C05.0 and C05.1) with about 6,9%; gum(C03.0 and 
C03.1) and retromolar pad(C06.2) with  6,6%, and oral 
mucosa (C06.0) with 6,0% (Table 1).
Lesions involving overlapping regions (C06.8) total 12,3% 
of  the malignancies, what indicates that sometimes due 
to a late diagnosis it’s difficult to determinate the original 
location of the tumour.
The distribution of the tumour histological types is shown 
in table 2. Squamous Cell Carcinomas SCC (Non Otherwise 
Specified = NOS) were the most common type. Non-epithe-
lial tumours were less than 3% of all malignant neoplasm’s 
(8000.3 and 9591.3). 
We found that 84,6% of the tumours were SCC (NOS) and 
that percentage is even higher when considering both the 
non-keratinized and keratinized spinocellular carcinomas 
(table 2).
The majority of the tumors were well differentiated – 36,2%. 
However, the analysis of this variable was not possible in 
30,1% of the cases.
Most of oral cancers were diagnosed at advanced stages (T3 
and T4) - 48,2% . Lymph node involvement (N) regardless 
of the tumour size was 40,6%.
Distant metastases were identified in 38 cases which repre-
sents 9,3% of the overall sample. The mean time for distant 
metastasis identification after the diagnosis was 496 days. 
Distant metastases affected mainly the lung. This organ 
stands for 47,4% of all the anatomical locations with me-
tastases involvement.
Combined radiation and surgery was provided to 20,8% of 
the cases. The radiation therapy alone, or combined with 
surgery or chemotherapy was provided to more than 60%. 
Radiation therapy included patients treated both with cu-
rative or palliative intent.
Clinical or histopathological evidence of recurrence was 
registered in 22,5% of the cases. Recurrence was not pos-
sible to be identified in 31,1% of the subjects due to follow 
up absence or late diagnosis (in some cases patients were 
never free of  disease, being impracticable to identified 
recurrence). 
At 1 year follow up, of all the cases studied, approxima-
tely 36,4% of the patients had deceased with documented 
tumour, while 38,9% exhibited no such evidence (Table 3). 
Regardless of  the clinical condition about 58,9% of the 
patients were alive. At 5 year follow up, 26,5% of all the 
sample cases were disease-free five years after treatment 
completion. Regarding only the individuals who were alive 
after the first year follow-up the disease-free group at the 
fifth year rises to 45,1% (Table 4). A high percentage of 
cases, 33,6%, were included in a non-applyable category. 
(These included the patients already dead and the ones that 
miss follow up appointments). 
Of the total sample 57,8%  had tabagic habits and 47,9% 
reported alcoholic habits. To notice is the fact that 43,8% 
of the patients had both habits. 
In 25 cases an association with other primary tumours was 
established, which represents of 6,8% of the sample. The 
main regions affected were the larynx and the lungs with 
percentages of 40% and 16%, respectively.
 
DIScuSSIon
This non-randomized sample is the totality of oral cancer 
cases diagnosed between 1997 and 1999 at Francisco Gentil 
Lisbon Centre of Portuguese Institute of Oncology (Centro 
de Lisboa do Instituto Português de Oncologia Francisco 
Gentil). We examined the available records of all patients 
with oral cancer. 
This research indicates that 80% of cases affected males. 
This finding is consistent with other oral cancer demogra-
phic reports(2,3,5).However gender is not a risk factor per 
se for oral cancer. This prevalence indicates the existence 
of other risk factors associated to the male gender, such as 
tabagic and alcoholic habits.
The most frequent anatomical location was the tongue. This 
is supported by other studies that showed the tongue as the 
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Anatomic Site Number 
of cases 
% 
Tongue (C01.9) (C02.0) (C02.1) 
(C02.2) (02.8) (C02.9) 
159 43 
Gum(C03.0) (C03.1) 24 6,6 
Mouth Floor (C04.0) (C04.1) 
(C04.8) (C04.9) 
69 18,9 










Overlapping  sites of several 
anatomic locations  
(C06.8) 
45 12,3 
Other locations  5 1,4 
Total 365 100,0 
Number  












Indiferentiated Carcinoma  
(8020.3) 
1 0,2 
Poligonal cells carcinoma   
(8034.3) 
1 0,2 















Neuroendocrine Carcinoma  
(8246.3) 
1 0,2 
Acinic cells carcinoma   
(8550.3) 
3 0,8 







Total 365 100,0 
1 year Follow Up Numberof cases %
Alive with tumor evidence 51 13,9 
Alive with metastasis evidence 5 1,3 
Alive without tumor evidence 142 38,9 
Alive with tumor recurrence 17 4,6 
Deseased with tumor evidence 133 36,4 
Others 17 4,5 
5 years follow up Numberof cases %
Alive with tumor evidence 3 0,8 
Alive with metastasis evidence 2 0,5 
Alive without tumor evidence 97 26,5 
Alive with tumor recurrence 7 1,9 
Deseased with tumor evidence 31 8,4 
Deseaced without tumor 
evidence 25 6,8 
Deceased with recurrence 41 11,2 
Deseaced with metastasis 
evidence 4 1,0 
Other 155 42,3 
table 1. Oral cancer cases according to the site of the primary 
tumor. table 2. Histological Distribution of all malignancies.
table 3. 1 year follow up.
table 4. 5 years follow up. 
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main organ involved, when excluding the lip regions(15-17). 
The existence of approximately 11% tumours involving over-
lapping regions, 74,3% of which are stage T4 is indicative 
of late diagnosis.   
The patients’ average age of 62,2 years-old along with the 
standard deviation of approximately 12 years were consistent 
with other reports in general, and confirms the  suggestion 
to adopt screening appointments for patients with certain 
risk factors. Based on our results, screening appointments 
targeted to individuals over 50 years old and/or alcohol 
consumers could raise the number of early diagnosis and 
therefore increase treatment outcome. Moreover, monitoring 
pre-malignant lesions may also contribute to early diagnosis 
of SCC(5). Our research indicates that the most frequent 
histopathological type of oral tumour is SCC (84,1%) which 
corroborates other studies findings (18).
Despite the progress in diagnosis and treatment of  oral 
cancer the survival rates are lower in comparison to other 
types of cancer. This may be related to late diagnosis in the 
majority of cases. In our report, T3 and T4 tumours were 
extremely high – 50% and the involvement of regional lymph 
nodes were present in 40,6% of the patients. Once that lymph 
nodes involvement is an oral cancer prognosis sign, histo-
logical analysis of the sentinel node may provide specific 
information about ganglia involvement circumventing the 
limitations of clinical and imaging methods (19-20).
In our sample a great number of patients received radiation 
treatment. Once that  radiotherapy is planned to be used 
in a great number of patients, a pre-treatment evaluation 
should be undertaken in order to apply preventive measures 
to minimize collateral effects (21-22).
At 1 year follow-up 40% of the patients were disease-free. 
This finding is similar to other authors’ studies(23). Our 5 
year follow-up indicates that the percentage of disease-free 
patients, 26,5%, is not as high as in other reports(16-18). 
These low results may be explained by the fact that our 
sample is from an oncological hospital, where many patients 
are referred to palliative treatment for advanced tumours 
and also because part of the population has no primary 
oral care assistance.
The majority of patients in this study had a history of tobac-
co use - 57,8%. The positive association between oral cancer 
and tobacco use is well documented by various authors who 
have shown that the risk of developing oral cancer is directly 
proportional to the number of cigarettes smoked per day 
and to the number of years as a smoker (24-25).
Alcohol consumers were approximately 50% of the total 
number of cases. The association between oral cancer and 
alcohol consumption may be explained in Portugal because 
it is one of the countries with the highest average alcohol 
consumption, namely 12,1 litres (25,57 U.S. pints) of pure 
alcohol per capita(26). Although it seems that alcohol is not 
a carcinogen per se, once it is metabolised active substances 
with carcinogenic potential are produced (27).
The interaction between alcohol and tobacco has been 
studied in order to determine the existence of a synergic me-
chanism predisposing to oral cancer. We found that 43,8% 
of the patients were both alcohol consumers and smokers. 
Excess risk of approximately 10 fold is associated with to-
bacco and alcohol use. Nowadays it is proposed that tobacco 
is an initiator while alcohol is a promoter, presumably by 
either increasing the permeability of mucosa lining cells to 
tobacco carcinogens or by cellular lesions induced directly 
by alcohol metabolism (28). Therefore primary prevention 
must favour a decrease in exposure to tobacco, alcohol and 
other carcinogenic agents.
The highest incidence of second tumours is found in the 
larynx and lung, which is in accordance with other author’s 
reports (29-30). However, our total percentage is lower, 
namely 6,1%.  This might be explained by the difficulty in 
distinguishing between two primary tumours.
Metastatic spread of oral SCC tends to increase with the size 
of the primary tumor. Metastases were observe after an ave-
rage time of 16,5 months. Therefore, within this timeframe 
clinical surveillance of patients with SCC must be scheduled 
in regular intervals in order to identify metastases. 
Because of the magnitude of the oral cancer problem, and 
because this is a tobacco and alcohol related cancer, serious 
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